Zusammenfassung
Bei einer Störung des Bewusstseins von leichter Schläfrigkeit oder Benommenheit bis zum tiefen Koma muss immer die Möglichkeit einer Intoxikation als Ursache einbezogen werden. Vergiftungen können bedingt sein durch:
-
Einnahme von Medikamenten, Drogen oder Giften in suizidaler Absicht
-
Überdosierung von Medikamenten und/oder illegalen Drogen
-
Nichtbeachtung von Wechselwirkungen oder Kontraindikationen bestimmter Medikamente
-
Verwechslung von Flüssigkeiten (irrtümliches Trinken toxischer Substanzen) oder Pilzen
-
Unfall: Einnahme toxischer Substanzen durch Kinder
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adityanjee, Munshi KR, Thampy A (2005) The syndrome of irreversible lithium-effectuated neurotoxicity. Clin Neuropharmacol 28:38–49
Altura BT, Altura BM (1981) Phencyclidine, lyserg acid diethyamid, and mescaline: cerebral artery spasm and hallucinogenic activity. Science 212:1051–1052
Amdisen A (1988) Clinical features and managemant of lithium poisoning. MedToxicol Advers Drug Exp 3:18–32
Anderson CE, Loomis GA (2003) Recognition and prevention of inhalant abuse. Am Fam Physician 68:869–874
Baca CT, Grant KJ (2007) What heroin users tell us about overdose. J Addict Dis 26:63–68
Bauer MS, Loipl R, Jagsch R et al (2008) Mortality in opioidmaintained patients after release from an addiction clinic. Eur Addict Res 14:82–91
Blackwell B (1981) Adverse effects of antidepressive drugs., part I. Monoamine oxidase inhibitors and tricyclics. Drugs 21:201–219
Bonnet U, Harries-Hedder K, Leweke M et al (2004) AWMF-Leit-linie: Cannabis-bezogene Störungen. Fortschr Neurol Psychiatr 72:318–329
Brent J (2001 ) Current management of ethylene glycol poisening. Drugs 61:979–988
Cameron RJ, Hungerford P, Dawson AH (2002) Efficacy of charcoal hemoperfusion in massice carbamazepine poisoning. J Toxicol Clin Toxicol 40:507–512
Chyka PA, Erdman AR, Manoquera AS et al (2007) Dextromethorphan poisoning: an evidence based consensus guideline for out-of-hospital management. Clin Toxolcol (Phila) 45:662–677
Clausen T, Anchersen K, Waal H (2007) Mortality prior to, during and after maintenence treatment (OMT): a national prospective cross registry study. Drug Alcohol Depend 94:151–157
Cobaugh DJ, Erdman AR, Booze LL et al (2007) Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol(Phila) 45:918–942
Cohen H, Hoffman RS, Howland MA (1997) Antidepressant poisining and treatment: a review and case illustration. J Pharm Prct 102:49–70
Correll CU, Leucht S, Kane JM (2004) Lower risk at tardive dyskinesia associated with second generation antipsychotics: a systematic review of 1-year-studies. Am J Psychiatry 161:414–425
Degenhardt L, Coffey C, Moran P et al (2007) The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction 102:1076–1084
Deng MZ, Chen GQ, Phillips MR (1990) Neuroleptic malignant syndrome in 12 of 9.792 chinese inpatients exporsed to neuroleptics: a prospective study. Am J Psychiatry 147:1149–1155
Dirks B (Hg) (2007) Die Notfallmedizin. Springer, Berlin Heidelberg New York Tokyo
El-Malakh RS, Abraham HD (2007) MDMA (Ecstasy). Ann Clin Psychiatry 19:45–52
Eyer F, Pfab R, Felgenhauer N (2006) Lithium poisoning: pharmacokinetics and clearence during different therapeutic measures. Clin Psychopharmacol 26:325–330
Flanagan RJ, Ives RJ (1994) Volatile substance abuse. Bull Narc 46:49–78
Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107–113
Gawin FH, Kleber HD, Byck R et al (1989) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46:117–121
Gold MS (1997) Cocain (and Crack): Clinical aspects. In: Lowison JH, Ruiz P, Millman RB et al (eds) Substance abuse: a comprehensive textbook. 3rd edition. Williams & Wilkins, Baltimore
Gonzales JP, Brogden RN (1988) Naltrexone. A review of ist pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drug 35:192–213
Gouzoulis-Mayfrank E, Hermle L, Kovar K-A et al (1996) Die Entaktogene: “Ecstasy„ (MDMA), “Eve„ (MDA) und andere ringsubstituierte Metamphetaminderivate. Eine neue Stoffklasse unter den illegalen Designer-Drogen? Nervenarzt 67:369–380
Halpern JH, Pope HG jr (2003) Hallucinogen persisting perception disorder: what do we now after 50 years? Drug Alcohol Depend 69:109–119
Harrigan EP, Miceli JJ, Anciano R et al (2004) A randomiced evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacology 24:62–69
Hassaballa HA, Balk RA (2003) Torsade de pointes associated with the administration of intravenous haloperidol: a review of the literature and practice guidelines for use. Expert Opin Drug Saf 2:543–547
Henry JA, Alexander CA, Sener EK (1995) Relative mortality from overdose of antidepressants. BMJ 310:221–224
Hinterhuber H, Haring Ch (1998) Unerwünschte Wirkungen, Kontraindikationen, überdosierung, Intoxikation. In: Riederer P, Laux G, Pöldinger W (Hg) Neuro-Psychopharmaka, Bd 4: Neuroleptika, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 144–165
Hopper JW, Su Z, Looby AR et al (2006) Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological mementary assessment study. Drug Alsohol Depend 85:221–235
Hunfeld NG, Westerman EM, Boswijk DJ et al (2006) Quetiapine in overdose: A clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit 28:185–189
Isbiter GK, Balit CR Whyte IM et al (2003) Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol 55:398–404
Iversen L (2003) Cannabis and the brain. Brain 126:1252–1270
Jeste DV, Caligiuri MP, Paulsen JS et al (1995) Risk of tardive dyskinesia in older patients. Arch Gen Psychiatry 52:756–765
Julien RM (1997) Drogen und Psychopharmaka. Spektrum, Heidelberg Berlin Oxford
Kandel D, Chen K (2000) Types of marihuana users in longitudinal course. J Stud Alcohol 61:367–378
Kardels B, Beine KH (2000) Alkoholismus-ein medizinischer Notfall. Notfall und Rettungsdienst 7:36–39
Kaspar S, Frey R, Schreinzer D (2001) Safety and tolerability of old and new antidepressants. In: den Boer JA, Westenberg H (eds) Focus on psychiatry. Antidepressants: selectivity or multiplicity? Benecke, Amsterdam, pp 157–169
Kelly TM, Donovan JE, Cornelius JR (2004) Predictors of problem drinking among older adolescent emergency department patients. J Emerg Med 27:209–218
Kielholz, Battegay R, Ladewig D (1972) Drogenabhängigkeiten. In: Kisker KP, Meyer JE, Müller M et al (Hg) Psychiatrie der Gegenwart, Bd II, Teil 2. Springer, Berlin Heidelberg New York Tokyo, S 477–564
Klotz U, Laux G (1996) Tranquillantien. Therapeutischer Einsatz und Pharmakologie, 2. Aufl. Wiss Verlagsgesellschaft, Stuttgart
Kraus L, Augustin R, Röder J (2006) Trends im Konsum von Alkohol, Tabak und illegalen Drogen. In: Deutsche Hauptstelle. für Suchtfragen (Hg) Jahrbuch Sucht 06. Neuland, Geesthacht, Kap 3
Kretz FJ, Löscher W, Peisdersky B et al (1990) Flumazenil (Anexate). Pharmakodynamik; Pharmakokinetik, Indikationen und Kontraindikationen. Med Welt 85:156–160
Laux G, Volz HP, Möller HJ (1995) Newer and older monoamino oxidase inhibitors. A comparative Profile. CNS Drugs 3:145–158
Leikin JB, Krantz AJ, Zell-Kanter M et al (1989) Clinical features and management of intoxication due to hallucinogenic drugs. Med Toxocol Adverse Drug Exp 4:324–350
Lerner AG, Gelkopf M, Skladman I et al (2003) Clonazepam treatment of lyserg acid diethylamid-induced hallucinogen persisting perception disorder with anxiaty features. Int Clin Psychopharmacol 18:101–105
Leucht S, Pitschel-Walz G, Abraham D et al (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a me-ta-analysis of randomized controlled studies. Schizophr Res 35:51–68
Leweke FM, Gerth CW, Klosterkötter J (2004) Cannabis associated. psychosis: current status of research. CNS Drug 18:895–910
Lieb R, Schütz CG, Pfister H et al (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68:195–207
Lofton AL, Klein-Schwartz W (2004) Evaluation of lamotrigin toxicity reported in poison centers. Ann Pharmacother 38:1811–1815
Lowenstein DH, Massa SM, Rowbotham MC et al (1987) Acute neurologic and psychiatric comklications associated with cocaine abuse. Am J Med 83:841–846
Madler C, Jauch KW, Werdan K et al (Hg) (2005) Das NAW-Buch. Akutmedizin der ersten 24 Stunden, 3. Aufl. Elsevier Urban & Fischer, München
Mahoney JJ 3rd, Kalechstein AD, De La Garza R 2nd et al (2008) Presencs and persistence of psychotic symptoms in cocaine versus methamphetamine-dependent participants. Am J Addict 17:83–98
Manoquerra AS, Erdmann AR, Woolf AD et al (2008) Valproic acid poisoning: an evidence-based consensus guideline for out-ofhospital management. Clin Toxicol (Phila) 46:661–676
Marino PL (ed) (2007) The ICU Book, 3rd edition. Lippincott Williams & Wilkins, Philadelphia
Marks J (1988) Technics of benzodiazepine withdrawal in clinical practice. A consensus workshop report. Med Toxicol 3:324–333
Maxwell JC (2001) Deaths related in the inhalation of volative substances in Texas 1988–1998. Am J Drug Alcohol Abuse 27:689–697
Meadows R, Verghese A (1996) Medical complications of glue sniffing. South Med J 98:455–462
Modestin J, Wehli MV, Stephan PL et al (2008) Evolution of neuroleptic-induced extrapyramidal syndrome under longterm neuroleptic treatment. Schizophr Res 100:97–107
Newton EH, Shih RD, Hoffman RS (1994) Cycling antidepressant overdose: a review of current management strategies. Am JEmerg Med 12:376–379
Nnadi CU, Mimiko OA, McCurtis HL et al (2005) Neuropsychiatric effect of cocaine use disorders. J Natl Med Assoc 97:1504–1515
Oetting ER, Edwards RW, Beauvais F (1988) Social and psychological factors underlying inhalant abuse. NIDA Res Monogr 85:172–203
Pederson W, Skrondal A (1999) Ecstasy and new patterns of drug use: a normal population study. Addiction 94:1695–1700
Perekonigg A, Lieb R, Höfler M et al (1999) Patterns of cannabic use, abuse and dependence over time: incidence and stability in a sample of 1228 adolescents. Addiction 94:1663–1678
Picard LS, Lindsay S, Strawn JR (2008) Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 28:530–535
Poser W, Böning J, Holzbach R et al (2006) Medikamentenabhängigkeit (Sedativa, Hypnotika, Analgetika, Psychostimulantien). In: Schmidt LG, Gastpar N, Falkai P, Gaebel W (Hg) Evidenzbasierte Suchtmedizin. Deutscher ärzteverlag, Köln
Poser W, Poser S (1996) Medikamente-Missbrauch und Abhängigkeit. Thieme, Stuttgart
Preuss U, Bahlmann M, Koller G et al (2000) Die Behandlung der Kokainabhängigkeit: Intoxikation, Entzug und Rückfallprophylaxe. Fortsch Neurol Psychiat 68:224–238
Schmidt IG, Gastpar M, Falkai P et al (2006) Evidenzbasierte Suchtmedizin. Behandlungsleitlinien bei substanzbezogenen Störungen. Deutscher ärztverlag, Köln
Schöpf J (1983) Withdrawal phenomena after long-term administration of benzodiazepines. Pharmacopsychiatry 16:1–8
Schöpf W (2003) Moderne Antidepressiva-wechseln, kombinieren und augmentieren. Steinkopff, Darmstadt
Simon R, Sonntag D, Bühringer G et al (2004) Cannabisbezogene Störungen: Umfang, Behandlungsbedarf und Behandlungsangebot in Deutschland. IFT München
Soyka M (1999) Alkoholabhängigkeit-Grundlagen und Therapie. Springer, Berlin Heidelberg New York Tokyo
Soyka M, Banzer K, Erbas B et al (2006) Substitutionsbehandlung Drogenabhängiger-rechtliche Grundlagen und neue Ergebnisse der Therapieforschung. Nervenheilkunde 25:286–294
Soyka M, Steinberg R, Vollmer M (1988) Entzugsphänomene bei schrittweisem Benzodiazepinentzug. Nervenarzt 59:744–748
Spavik, B, Maline DI Kozyrev VN et al (2000) Frequency of neuroleptic malignant syndrome in a large psychiatric hospital in Moscow. Eur Psychiatry 15:330–333
Spiller HA (2001) Management of carbamazepine overdose. Pediatr Emerg Care 17:452–456
Sternbach H (1991) The serotonin syndrom. Am J Psychiatry 148:705–713
Tait RJ, Hulse GK, Robertson SI et al (2002) Multiple hospital presentations by adolescents who use alcohol or other drugs. Addiction 97:1269–1275
Te Wildt BT, Andreis C, Auffart I et al (2006) Alcohol related conditions represent a major psychiatric problem in emergency departments. Emerg Med J 23:428–430
Thomasius R (1999) Ecstasy-Wirkungen, Risiken, Interventionen. Enke, Stuttgart
Thomasius R, Goutzoulis-Mayfranck E (2006) Psychische und verhaltensbezogene Störungen durch Kokain, Amphetamine, Ecstasy und Halluzinogene. In: Schmidt LG, Gastpar M, Falkai P, Gaebel W (Hg) Evidenzbasierte Suchtmedizin. Behandlungsleitlinien suchtbezogener Störungen. Deutscher Ärzteverlag Köln, S 241–270
Thundiyil JG, Kearney TE, Olson KR (2007) Evolving epidemiology of drug induced seizures reported to a Poison Control Center System. J Med Toxicol 3:15–19
Tossmann HP (2006) Cannabis-Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle für Suchtfragen (Hg) Jahrbuch Sucht 06. Neuland, Geesthacht, S 73–86
Tremeau F, Darreye A, Staner L et al (2008) Suicidality in opioiddependent subjects. Am J Addict 17:184–194
Troisi A, Pasini A, Saracco M et al (1998) Psychiatric symptoms in male cannabis users not using other illicit drugs. Addiction 93:487–492
Waring WS, Good AM, Bateman DN (2007) Lack of significant toxicity after mirtazepine overdose: a five year review of cases admitted to a regional toxicology unit. Clin Toxicol (Phila) 45:45–50
Weilemann S, Lorenz J, Voigtländer T (2007) Internistische Intensivmedizin und Notfalltherapie. Springer, Berlin Heidelberg New York Tokyo
Wilson AD, Howell C, Waring WS (2007) Venlafaxine ingestion is associated with rhabdomyolysis in adults: a case series. J Toxicol Sci 32:97–101
Wu LT, Ringwalt CL (2006) Inhalant use and disorders among adults in the United States. Drug Alcohol Depend 85: 1–11
Zilker T (1998) Intoxikationen. In: Hewer W, Rössler W (Hg) Das Notfall Psychiatrie Buch. Urban & Schwarzenberg, München Wien Baltimore S 194–212
Zullino DF, Krenz S, Eap CB et al (2008) Over-and underreporting of recent drug use in subjects entering an inpatient detoxification unit. Eur J Med Res 13:15–20
Rights and permissions
Copyright information
© 2009 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2009). Intoxikationen. In: Der psychiatrische Notfall. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-27243-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-27243-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-27242-7
Online ISBN: 978-3-540-27243-4
eBook Packages: Medicine (German Language)